---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013536"
form_type: "8-K"
ticker: "STSS"
cik: "0001737995"
company_name: "Sharps Technology Inc."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-20T00:02:56.932401+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sharps begins first commercial shipments; transitions to revenue-generating stage

## Summary
- Initiated shipments under three customer orders; first commercial revenue from $500K total purchase commitments.
- Delivered initial $400K SoloGard order under $50M supply agreement with U.S. IV solutions leader.
- Shipped $100K SecureGard order to Hungarian vaccine provider; first commercial order.
- Began 200K unit shipment of 1mL syringes for Botox delivery pens to Swiss injectable therapies provider.
- CEO Hayes says company now a commercial-stage, revenue-generating firm after R&D and manufacturing investments.

## SEC filing metadata
- accession: 0001641172-25-013536
- form_type: 8-K
- ticker: STSS
- cik: 0001737995
- company_name: Sharps Technology Inc.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737995/000164117225013536/0001641172-25-013536-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737995/000164117225013536/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013536
- JSON: https://secwatch.observer/filing/0001641172-25-013536.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013536.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.